480 Arsenal Street, Suite 130Watertown, MA 02472
Nancy Simonian, M.D.
Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics. Syros’ initial focus is in cancer, but the company platform will also be applicable to other therapeutic areas.
Doug Cole is on the Board of Directors.